Tag results:
lymphocytes
Immunology of Infectious Disease News
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients
[Annals of Neurology] Scientists investigated prospectively humoral and cellular responses to SARS-CoV-2 mRNA vaccination in 82 patients with neuroimmunologic disorders on anti-CD20 therapy and 82 age- and sex-matched healthy controls.
Immunology of Infectious Disease News
Single-Cell Immune Profiling Reveals Functional Diversity of T Cells in Tuberculous Pleural Effusion
[Journal of Experimental Medicine] Using single-cell transcriptomics and T cell receptor sequencing, scientists analyzed mononuclear cell populations in paired pleural fluid and peripheral blood of tuberculous pleural effusion patients.
Immunology of Infectious Disease News
SARS-CoV-2 Vaccination Induces Immunological T Cell Memory Able to Cross-Recognize Variants from Alpha to Omicron
[Cell] In subjects ∼6 months post-vaccination, 90% and 87% of memory T cell responses were preserved against variants on average by AIM assay, and 84% and 85% preserved against Omicron.
Immune Regulation News
Effector Memory CD4+ T Cells Induce Damaging Innate Inflammation and Autoimmune Pathology by Engaging CD40 and TNFR on Myeloid Cells
[Science Immunology] Investigators identified a critical signaling node that was engaged by effector memory T cells to mobilize a broad proinflammatory program in the innate immune system.
Immunology of Infectious Disease News
Adenosine Receptor 2a Agonists Target Mouse CD11c+T-Bet+ B Cells in Infection and Autoimmunity
[Nature Communications] Researchers showed that administration of the A2A receptor agonist CGS-21680 depleted established CD11c+T-bet+ B cells in ehrlichial-infected mice, in a B cell-intrinsic manner.
Immunology of Infectious Disease News
Synthetic Multiantigen MVA Vaccine COH04S1 Protects against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates
[NPJ Vaccines] The authors demonstrated that intramuscular or intranasal vaccination of Syrian hamsters with COH04S1 induced robust Th1-biased antigen-specific humoral immunity and cross-neutralizing antibodies.